Study suggests a single dose of HPV vaccine provides years of protection from cancer

by Rita Reyburn and Professor Fiona Russell,University of MelbourneCredit: AI-generated imageAt some point in their life, it's estimated that around 80% of people will be infected with the h

Updated on: January 16,2024

Study suggests a single dose of HPV vaccine provides years of protection from cancer

by Rita Reyburn and Professor Fiona Russell,University of MelbourneCredit: AI-generated imageAt some point in their life, it's estimated that around 80% of people will be infected with the h

Updated on:January 16,2024

Study proposes streamlined approach to developing cancer drugs

by Tom Dinki,University at BuffaloBlessing Ogboo works in the Natural Sciences Complex chemistry lab of David Heppner. Credit: Douglas Levere / Univeristy at BuffaloDrug discovery can be a frust

Updated on: June 25,2024

Study proposes streamlined approach to developing cancer drugs

by Tom Dinki,University at BuffaloBlessing Ogboo works in the Natural Sciences Complex chemistry lab of David Heppner. Credit: Douglas Levere / Univeristy at BuffaloDrug discovery can be a frust

Updated on:June 25,2024

New imaging detects deadly lung and prostate cancers, may improve treatment

by Jim Stallard,Memorial Sloan Kettering Cancer CenterA new imaging technology developed in the laboratories of Dr. Jason Lewis and Dr. Charles Rudin could improve detection and treatment of cer

Updated on: July 08,2024

New imaging detects deadly lung and prostate cancers, may improve treatment

by Jim Stallard,Memorial Sloan Kettering Cancer CenterA new imaging technology developed in the laboratories of Dr. Jason Lewis and Dr. Charles Rudin could improve detection and treatment of cer

Updated on:July 08,2024

Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease

November 2023Lara C. Pullen, PhDA new study reports on the long-term risk for coronary heart disease (CHD) in blood or marrow transplant (BMT) recipients and identifies individuals who are at high ris

Updated on: February 18,2024

Blood, Marrow Transplant Recipients at Increased Risk for Coronary Heart Disease

November 2023Lara C. Pullen, PhDA new study reports on the long-term risk for coronary heart disease (CHD) in blood or marrow transplant (BMT) recipients and identifies individuals who are at high ris

Updated on:February 18,2024

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on: May 11,2024

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on:May 11,2024

A new approach for bolstering the ability of T cells to fight cancer

by Monash UniversityCredit: CC0 Public DomainA collaborative study led by the Monash Biomedicine Discovery Institute (BDI) has discovered a new immune checkpoint that may be exploited for cancer

Updated on: March 25,2024

A new approach for bolstering the ability of T cells to fight cancer

by Monash UniversityCredit: CC0 Public DomainA collaborative study led by the Monash Biomedicine Discovery Institute (BDI) has discovered a new immune checkpoint that may be exploited for cancer

Updated on:March 25,2024

Preventing 'chemo brain' with antioxidants targeting the spinal fluid

by Children's Hospital BostonGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.009Up to three quarters of patients receiving cancer chemotherapy suffer from &

Updated on: February 01,2024

Preventing 'chemo brain' with antioxidants targeting the spinal fluid

by Children's Hospital BostonGraphical abstract. Credit:Neuron(2022). DOI: 10.1016/j.neuron.2022.08.009Up to three quarters of patients receiving cancer chemotherapy suffer from &

Updated on:February 01,2024

Fine-tuning 3D lab-grown mini tumors to help predict how patients respond to cancer therapies

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainScientists from the UCLA Jonsson Comprehensive Cancer Center have developed a new method to bioprint miniature tumor organ

Updated on: January 08,2024

Fine-tuning 3D lab-grown mini tumors to help predict how patients respond to cancer therapies

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainScientists from the UCLA Jonsson Comprehensive Cancer Center have developed a new method to bioprint miniature tumor organ

Updated on:January 08,2024

Prognosis of multiple myeloma has improved since 2000

by Elana GotkineFor patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in&n

Updated on: January 22,2024

Prognosis of multiple myeloma has improved since 2000

by Elana GotkineFor patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in&n

Updated on:January 22,2024

A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

by Compuscript LtdSchematic diagram and pharmacokinetics of HER2-TP-cy5.5 and HER-TA-cy5.5 conjugate synthesis. (A) Schematic representation of the utilization of HER2-targeting peptide/antibody and C

Updated on: February 01,2024

A HER2-targeting peptide drug conjugate with better penetrability for effective breast cancer therapy

by Compuscript LtdSchematic diagram and pharmacokinetics of HER2-TP-cy5.5 and HER-TA-cy5.5 conjugate synthesis. (A) Schematic representation of the utilization of HER2-targeting peptide/antibody and C

Updated on:February 01,2024

Scientists enhance cell-based therapy to destroy solid tumors

byThe Wistar InstituteGraphical abstract. Credit:Molecular Therapy - Oncolytics(2023). DOI: 10.1016/j.omto.2023.100744Wistar researchers successfully tested a simple intervention tha

Updated on: January 25,2024

Scientists enhance cell-based therapy to destroy solid tumors

byThe Wistar InstituteGraphical abstract. Credit:Molecular Therapy - Oncolytics(2023). DOI: 10.1016/j.omto.2023.100744Wistar researchers successfully tested a simple intervention tha

Updated on:January 25,2024

Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

byInstitute of Cancer ResearchImmunofluorescent image of autophagosomes in multiple myeloma cells. Credit: Institute of Cancer ResearchCombining five existing drugs can keep a highly aggressive

Updated on: January 15,2024

Next-generation trial shows five-drug combo can keep 'ultra-high-risk' bone marrow cancer at bay

byInstitute of Cancer ResearchImmunofluorescent image of autophagosomes in multiple myeloma cells. Credit: Institute of Cancer ResearchCombining five existing drugs can keep a highly aggressive

Updated on:January 15,2024